- Home
- UFI vs ADAG Comparison
UFI vs ADAG Comparison
Compare UFI & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- ADAG
- Stock Information
- Founded
- UFI 1969
- ADAG 2011
- Country
- UFI United States
- ADAG China
- Employees
- UFI N/A
- ADAG N/A
- Industry
- UFI Textiles
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- ADAG Health Care
- Exchange
- UFI Nasdaq
- ADAG Nasdaq
- Market Cap
- UFI 86.8M
- ADAG 90.8M
- IPO Year
- UFI N/A
- ADAG 2021
- Fundamental
- Price
- UFI $4.48
- ADAG $1.92
- Analyst Decision
- UFI
- ADAG Strong Buy
- Analyst Count
- UFI 0
- ADAG 1
- Target Price
- UFI N/A
- ADAG $8.00
- AVG Volume (30 Days)
- UFI 37.2K
- ADAG 92.4K
- Earning Date
- UFI 08-20-2025
- ADAG 08-12-2025
- Dividend Yield
- UFI N/A
- ADAG N/A
- EPS Growth
- UFI N/A
- ADAG N/A
- EPS
- UFI N/A
- ADAG N/A
- Revenue
- UFI $590,261,000.00
- ADAG $103,204.00
- Revenue This Year
- UFI $1.08
- ADAG $9,289.17
- Revenue Next Year
- UFI $9.96
- ADAG $36.84
- P/E Ratio
- UFI N/A
- ADAG N/A
- Revenue Growth
- UFI 2.51
- ADAG N/A
- 52 Week Low
- UFI $4.25
- ADAG $1.33
- 52 Week High
- UFI $7.91
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- UFI 32.00
- ADAG 50.00
- Support Level
- UFI $4.77
- ADAG $1.87
- Resistance Level
- UFI $4.75
- ADAG $2.17
- Average True Range (ATR)
- UFI 0.13
- ADAG 0.17
- MACD
- UFI -0.02
- ADAG 0.01
- Stochastic Oscillator
- UFI 8.24
- ADAG 56.14
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.